Regulatory GSK claims FDA okay for first oral carbapenem antibiotic PharmaphorumGSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi.Infectious DiseaseRead full story pharminent June 18, 2026 (Last updated: June 19, 2026) Pharmaphorum GSK has helped top up the antibiotic armamentarium in the US, after securing the first FDA approval for an oral carbapenem, Utebzi. Infectious Disease Read full story Post navigation Previous: LG AI Research and D&D Pharmatech sign agreement for oral peptide drugsNext: Cardio biotech Kardigan binds off $400M upsized IPO Related Stories Regulatory Scholar Rock’s muscle-targeting SMA therapy Isemblyd lands FDA approval pharminent September 14, 2026 Regulatory Psychedelic therapies ride wave of public favor into FDA hearing pharminent September 14, 2026 Regulatory Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion pharminent September 10, 2026